Introduction
Photodynamic therapy (PDT) has been developed as a treatment for cancer and nonmalignant diseases such as macular degeneration. It is based on the photochemical reaction between a photosensitising agent (PS), most often porphyrins (Kessel and Dougherty, 1999; Pandey and Zheng, 2000) , and light of an appropriate dose and wavelength. The result is a photochemical conversion of molecular oxygen ( One of the most promising second-generation photosensitisers is 5,10,15,20-tetra-(mhydroxyphenyl)chlorin (mTHPC, Foscan ® ), which was approved in 2002 for the palliative treatment of head and neck cancer. Foscan is activated at a wavelength of 652 nm which enables a light penetration of at least 1 cm and has a high quantum yield of singlet oxygen generation. (Bonnett et al., 1989; Senge and Brandt, 2011; Senge, 2012) . Although Foscan is one of the most effective compounds for PDT of cancer lesions, including oesophageal cancer (Javaid et al., 2002; Lovat et al., 2005) , it still has a number of disadvantages, e.g., prolonged skin photosensitivity. The interval between injection and light administration is several days, and patients are restricted to limited light exposures during that time. Foscan is also prone to form aggregates, leading to low levels of the substance in the target tissue (Leung et al., 2002) . On-going research is hence, focused on the development of new PS with optimised photophysicochemical and pharmacological properties (Castano et al., 2004; Nyman and Hynninen, 2004) and indeed the optimisation of formulation and delivery strategies for existing compounds (Paszko et al., 2011) .
One means to improve drug delivery is the use of submicron liposomal formulations. These can accumulate in tumour tissues via the enhanced permeability and retention (EPR) effect as a result of their size (Maeda et al., 2000) . However, also as a result of their size, conventional liposomes are rapidly removed from the circulation by macrophages of the reticuloendothelial system (RES). As a countermeasure, sterically stabilised systems have been developed (Torchilin, 2005) . The most widely used polymeric stabiliser is polyethylene glycol (PEG), a water-soluble polymer that exhibits low toxicity, is non-immunogenic and can be prepared synthetically with high purity and in large quantities (Kepczynski et al., 2006) .
To further enhance the therapeutic effect and to specifically deliver drugs to the tumour site, targeted liposomes can be prepared, using surface moieties recognising cell surface antigens or receptors primarily or over-expressed on cancer cells (Moghimi et al., 2001; Torchilin, 2006) . One of the most widely used ligands for anticancer delivery is transferrin (Anabousi et al., 2006; Li et al., 2009) , which is exploiting receptor mediated endocytosis followed by release of the drug into the cell (van Renswoude et al., 1982) . The transferrin receptor (TfR) is ubiquitously expressed on healthy cells, however, many cancers exhibit vastly increased quantities of TfR (Daniels et al., 2006) . Moreover, the transferrin receptor shows a high turnover on tumour cells due to their increased iron consumption (Singh, 1999) . Whilst PDT can be used for many malignancies, we are mainly interested in oesophageal adenocarcinoma, one the fastest increasing cancer types with poor prognosis (Pohl and Welch, 2005) . The major risk factor is Barrett's metaplasia which develops as a consequence of chronic gastro-oesophageal reflux disease (GORD) (Falk, 2001) . Interestingly, the progression of Barrett's metaplasia to adenocarcinoma, correlates well with expression levels of iron import proteins including TfR (Boult et al., 2008) .. New therapies have been developed including endoscopic resection with oesophageal preservation, which minimise the morbidity and mortality of traditional forms of oesophagectomy (Haringsma, 2002) . PDT is also used in oesophageal cancer treatment, but irrespective of the photosensitiser used, still has drawbacks (Javaid et al., 2002; Kelty et al., 2002; Lovat et al., 2005) .
In order to improve the targeting of established PS such as Foscan we aimed to develop plain and transferrin-modified liposomal formulations of the drug. Transferrin was conjugated to PEGylated liposomes and the light/dark cytotoxic effect of the systems was determined and compared with pure drug as well as plain and non-Tf-modified PEGylated liposomes. were purchased from Invitrogen (Dun Laoghaire, Ireland). Paraformaldehyde was obtained from Acros Organic (Dublin, Ireland). Foscan was prepared as described previously (Berenbaum and Bonnett, 1982) .
Experimental Methods

Liposome preparation
Liposomes were prepared using the lipid film method. Conventional (i.e., non-PEGylated) liposomes were composed of 18 mg/ml of dipalmitoylphosphatidylcholine ( 
Conjugation of transferrin to liposomes
The conjugation of Tf to liposomes was achieved using a previously published method of EDC and S-NHS-mediated amide bond formation between the carboxyl groups of DSPE-PEG-COOH and free amine groups of the transferrin molecule (Gaspar et al., 2012) . Briefly, to 1 ml of liposomes (lipid concentration: 10 µmol/ml), 1 ml of PBS, 180 μl of S-NHS and 180 μl of EDC, both freshly prepared 0.25 M in PBS, were added. This mixture was allowed to incubate for 10 min at room temperature. Then, 125 µg of Tf per µmol of lipid was added and gently agitated overnight at 4ºC. The unbound protein was separated from the liposomes by ultracentrifugation at 250,000 g for 3 h (15ºC) in a Beckman LM-80 ultracentrifuge. After ultracentrifugation, the pelleted liposomes were re-suspended with buffer and Tf binding efficiency was determined using a micro BCA protein assay according to the manufacturer's instructions.
Physicochemical characterisation of liposomes
Liposomes were characterised in terms of mean size, ζ-potential, lipid concentration, Foscan content and Tf conjugation efficiency. Mean size and polydispersity index (PdI) were measured by laser light scattering and ζ-potential by laser Doppler electrophoresis using a ZetaSizer, Nano Series (Malvern Instruments, Malvern, UK), after appropriate dilution of the liposomal suspensions in buffer at 25ºC. The PdI ranges from 0-1 with the higher value representing the highest degree of heterogeneity. The phospholipid content of liposomal suspensions was determined using Stewart's assay (Stewart, 1980) . The concentration of encapsulated Foscan was quantified via a fluorimetric assay. Triton X-100 was added to liposomal samples to a final concentration of 1% (v/v). Samples were measured in a plate reader (FLUOstar OPTIMA, BMG Labtech, Offenburg, Germany) at excitation and emission wavelengths of 405 and 650 nm, respectively. Samples were diluted with PBS when necessary. Tf conjugated to liposomes was quantified according to procedure applied in previous studies Anabousi et al., 2005) . Briefly, 400 µl of methanol was added to the liposome suspension (100 µl) and the mixture was centrifuged for 10 s at 9000 g. Then, 200 µl of chloroform was added and the sample was centrifuged again for 10 s at 9000 g. For phase separation, 300 µl of water was added to the mixture, followed by one min centrifugation at 9000 g. The upper phase was removed and a further 300 µl of methanol was added to the sample and centrifuged for 10 s at 9000 g in order to obtain a protein pellet. The supernatant was removed and the protein pellet was dried and resuspended in PBS buffer. The concentration of Tf was determined using a bicinchoninic acid protein assay kit (Smith et al., 1985) and BSA as a standard. The absorbance was measured at 595 nm in a plate reader (FLUOstar OPTIMA). The coupling efficiency was calculated as µg Tf/µmol PL.
Cell culture
Human oesophageal squamous cell carcinoma OE21 cells were cultured in RPMI 1640 medium supplemented with 10% inactivated foetal bovine serum and 1%
penicillin/streptomycin. Cells of passage numbers 10-35 were grown in culture flasks (Nunc, Denmark) and subcultured using a 0.25% trypsin/EDTA solution once confluence of 80-90% was reached. The culture medium was changed every other day.
Western blot
Cell lysate was collected from OE21 cells grown in 6-well plates until 80-90% of confluence.
Cells from three different passages were used in this study. Cells were washed three times with ice-cold PBS followed by cell homogenisation in freshly prepared lysis buffer containing 6% aprotinin and 1% leupeptin. Cells lysates were then sonicated twice for 10 s and centrifuged for 20 min at 10,000 rpm (4°C). The total amount of protein was determined by micro BCA protein assay according to the manufacturer's instructions. Samples were then diluted to equal concentration of protein. Six microlitres of loading buffer were added to each sample and the mixture was heated at to 95ºC for 5 min, followed by loading samples (18 µl) onto a 10% SDS gel. Electrophoresis was carried out at 110 V. The protein bands were then transferred onto Immuno-Blot PVDF membranes (Bio-Rad) at 25 V for 30 min. Blots were blocked in PBS containing 5% (w/v) BSA for at least 1 h at room temperature. After blocking, blots were incubated overnight with the anti-CD71 primary antibody (1:200) at 4°C. Membranes were then washed with PBS and incubated with the secondary anti-mouse IgG antibody (1:12,500) for 1 h at room temperature. Peroxidase activity was detected using the Immobilon Western Chemiluminescent HRP substrate and blots were captured using a
ChemiDoc system (Bio-Rad).
Confocal laser scanning microscopy
OE21 cells were seeded in 96-well glass bottom plates and left overnight to provide sufficient time for the cells to attach. Transferrin-modified liposomal formulations (at a concentration of 1.5 µM of Foscan) were added to the cells for 24 h. Untreated cells were used as control.
Cells were fixed with 4% paraformaldehyde solution washed twice with PBS, and then 0.1%
of Triton X-100 was added in order to permeabilise cell membranes. Cells were washed again twice with PBS and blocked in PBS-BSA (1%) solution for 15 min, followed by washing with PBS. Next, cells were incubated with anti-CD71 primary antibody (1:50) for 1.5 h at room temperature. Cells were then blocked in PBS-BSA (1%) solution for 15 min and washed with PBS. Secondary anti-mouse antibody labelled with Alexa Fluor 647 was added
(1:300) and incubated for 1 h at room temperature, followed by washing with PBS.
Subsequently, cells were stained with FITC-labelled phalloidin to visualise F-actin and Hoechst 33342 to counterstain the nuclei, respectively. Images were obtained using 63× oil immersion objectives on a Zeiss LSM Meta 510 confocal laser scanning microscope with the instrument settings adjusted so that no positive signal was observed in the channel corresponding to fluorescence for the isotypic controls.
Phototoxicity assay
The cytotoxicity of Foscan-loaded liposomal formulations was determined in OE21 cell lines using an MTT assay (Tim, 1983) . OE21 cells were seeded at 3000 cells/well into 96-well plates and incubated at 37°C in a 5% CO 2 incubator for 48 h, in order to provide sufficient time for the cells to attach and resume growth. Tryptan blue was used when cells were counted using a haematocytometer. Twenty-four hours post irradiation, cell survival was assessed by MTT assay according to manufacturer's instruction. The resulting absorbance, indicative of remaining cellular activity, was read at 570 nm using a Wallac Victor2 plate reader (Perking Elmer, Singapore).
Intracellular uptake by high content analysis
OE21 cells were grown and treated exactly as described above minus the MTT assay. Instead, cells were washed with PBS and fixed with 4% paraformaldehyde solution and then stained with FITC-labelled phalloidin to visualise F-actin and Hoechst 33342 to stain the nuclei for 1 h. After that time, cells were washed three times with PBS and then plates were resuspended with 100 µl of PBS and stored at 4°C in the dark until analysis. Images were obtained using an InCell 1000 high content system (GE Healthcare, Piscataway, NJ) using a total of 10 fields 13 per well at 10× magnification using three filters: blue (excitation 345 nm and emission 435 nm), green (excitation 475 nm and emission 535 nm) and red (excitation 560 nm and emission 700 nm). Image analysis was performed using the InCell 1000 image analyser (GE Healthcare, Piscataway, NJ). At least 3000 individual cells were imaged and analysed using
InCell Foscan parameters such as Foscan intensity determined by F-actin stain and Foscan.
Stain parameters were recorded numerically for individual cells in the field as well as average values per field and per well.
Statistical analysis
Each experiment was repeated a minimum of three times. Data are presented as mean±SEM (n), where n is the number of observations. Differences among more than two group means were determined by one-way analyses of variance (ANOVA). Averages and SEM were plotted using Graphpad Prism version 5.0 (GraphPad Software, USA). respectively. The size of liposomes consistently ranged from 100 nm to 150 nm, both before and after gel filtration. Polydispersity indices (PdI) were generally ≤ 0.22.
Results and Discussion
Liposomes have been used as vehicles for anti-cancer drug delivery for many years, mainly due to their biocompatibility and the opportunity to incorporate both hydrophilic and hydrophobic compounds (Torchilin, 2005) . The addition of moieties such as vitamins, glycoproteins, peptides, oligonucleotide aptamers and antibodies enhances tumour delivery and reduces toxicity to healthy tissues (Torchilin, 2007) . When adding such groups, it is pivotal that biological properties of the ligands (e.g., target recognition and binding efficiency) and drug loading efficiency of the carries remain unaffected (Anabousi et al., 2005) . In this context, the covalent modification using polyethylene glycol (PEG)-linked lipid residues has become a promising strategy Gijsens et al., 2002; Derycke et al., 2004; Anabousi et al., 2005; Bakowsky et al., 2008) . In order to couple transferrin to liposomes, we used the formation of an amide bound between the carboxylic groups of the linker lipid, DSPE-PEG-COOH, and free amino groups of the transferrin in the presence of a water-soluble carbodiimide (EDC). The reaction of carboxyl groups in the presence of EDC forms an amine-intermediate which then reacts with S-NHS to yield a reactive NHS ester capable of reacting with amino groups of Tf to yield a stable amide bond (Ishida et al., 2001; Anabousi et al., 2005) . The physicochemical properties of these new liposomes, i.e., particle size, PdI and ζ-potential, before and after coupling of Tf, are shown in Table 2 . No significant changes in any of the measured parameters were observed after conjugation of Tf. Approximately 40 µg Tf were conjugated per 1 µmol of phospholipids, which corresponded to a coupling efficiency of 31%.
Functional expression of TfR has previously been demonstrated in the oesophageal adenocarcinoma cell lines, OE33 and SEG-1 (Boult et al., 2008) . To assess if the OE21 cells used in our study also express TfR, Western blot analysis and immunocytochemical staining
were performed. Figure 1A shows TfR expression (red) in OE21 cells as obtained by confocal laser scanning microscopy. In Figure 1B Non-encapsulated Foscan also exhibited a photocytotoxicity, although at slightly lower levels than corresponding concentrations of plain and PEGylated liposomes. This effect was generally more pronounced at the highest concentration (i.e., 2 µM). Surprisingly, transferrinmodified liposomes, showed a profoundly lower cytotoxic effect upon irradiation, even after 24 h of incubation. No dark toxicity was observed in any of the formulations used [data not shown]. We and others have previously shown that Tf modification of drugs or drug delivery systems can improve their efficiency in cancer therapy (Derycke et al., 2004; Gaspar et al., 2012) . Several different cancer types were used in these studies, and it was demonstrated that Tf-targeted liposomes were indeed promising vehicles for delivering chemotherapeutic agents that can be encapsulated at high levels over extended periods of time such as doxorubicin to, e.g., non-small cell lung cancer (Anabousi et al., 2006; Gaspar et al., 2012) , hepatocellular carcinoma (Li et al., 2009) , leukaemia (Wu et al., 2007) Whilst data obtained with AlPcS4 were quite promising (Gijsens et al., 2002; Derycke et al., 2004) , the liposomally encapsulated hypericin was much less effective . It was suggested that significant amounts of hypericin were leaking from the PEGylated liposomes, thus, reducing their efficiency .
Our results also indicated that Tf-modified liposomes did not improve the efficiency of Foscan in oesophageal cancer. Consequently, we attempted to determine, whether the anti- However, all our experiments were performed at 37C only. As shown in Figure 4 the amounts of photosensitiser within the cells were similar in all cases and after 24 h, no differences were visible in the maxima. Even if Foscan was released from liposomes at 37C, Figure 4 indicated that the photosensitiser was still taken up by the cells at the same rate, thus destabilisation of Tf-liposomes is the only explanation. Hefesha et al. also noticed that positively charged liposomes had a faster transfer rate than negative ones, but the maximum amount transferred was almost identical. In our experiments all formulations were negatively charged and the differences between them were not significant. Moreover, the saturation degree or acyl chain length may have had an influence. Saturated lipids showed faster transfer rate than unsaturated in experiment performed at 37C (all our lipids were saturated), and the transfer rate was also faster for phospholipids with longer chains. In our studies, however, only DPPC was used.
It has been reported that the size of Tf-modified liposomes can regulate the selectivity of these vehicles to different tissues (Hatakeyama et al., 2004) . Small size, i.e., less than 80 nm, was an important factor for the tissue targeting of Tf-targeted liposomes to the liver and the brain, whilst the heart was able to take up both small and large (140nm) liposomes. In a different study, Sakeguchi and colleagues described that the internalisation of Tf-modified, pH-sensitive, fusogenic liposome-lipoplex hybrid complexes was inversely correlated to expression levels of TfR in a variety of cell lines (Sakaguchi et al., 2008 
Conclusions
This is the first study reporting the effect of Tf-targeted liposomes on an oesophageal cancer cell line. Whilst Tf-modification of drugs and drug delivery systems has in the past led to very promising results in other cancer types, our results indicated that in this specific case, targeting of the TfR did not improve the efficacy of the formulation. If the observation is due to the nature of the cell type (i.e., TfR recycling) or indeed due to issues with the formulation (i.e., size, leakage of the payload or transformation form holo-to apo-transferrin) needs to be determined. 
